Historical record - last NADAC effective date: 1/1/2016
Product Information
KINERET 100 MG/0.67 ML SYRINGE is a brand product labeled by Swedish Orphan Biovitrum AB (publ), priced at $192.3106 per ML under NDC 66658023428. Its NADAC has been published 161 times since Dec 18, 2013.
Strength
100 mg/.67mL
Manufacturer
Swedish Orphan Biovitrum AB (publ)NDC
66658023428
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
1/1/2016
Active Ingredients
ANAKINRAApproval Type
Biologic (BLA)
FDA Application
BLA103950On Market Since
12/15/2009
Pharmacological Classes
Price Statistics
The NADAC for KINERET 100 MG/0.67 ML SYRINGE has been published 161 times since Dec 18, 2013, and over the history we have for it it has risen 41.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $192.3106 per ML |
|---|---|
| All-time high | $192.3106 (Jan 11, 2017) |
| All-time low | $136.2476 (Dec 18, 2013) |
| Median price | $176.4317 |
| Average price | $171.3253 |
| Largest weekly change | +9.0% (Sep 10, 2014) |
| Weeks tracked | 161 |
| Tracking since | Dec 18, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+41.1%
Last surveyed Jan 11, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the anakinra market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Swedish Orphan Biovitrum AB (publ) manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
anakinra market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KINERET 100 MG/0.67 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for KINERET 100 MG/0.67 ML SYRINGE, manufactured by Swedish Orphan Biovitrum AB (publ), is $192.3106 per ML (NDC 66658023428), effective Jan 11, 2017.
How has the price of KINERET 100 MG/0.67 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for KINERET 100 MG/0.67 ML SYRINGE has risen 41.1%. It has been tracked across 161 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for KINERET 100 MG/0.67 ML SYRINGE?
Since Dec 18, 2013, the NADAC for KINERET 100 MG/0.67 ML SYRINGE has ranged from a low of $136.2476 (Dec 18, 2013) to a high of $192.3106 (Jan 11, 2017), with a median of $176.4317 per ML.
Are there cheaper alternatives to KINERET 100 MG/0.67 ML SYRINGE?
No other NADAC-published product currently shares the active ingredient and strength of KINERET 100 MG/0.67 ML SYRINGE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures KINERET 100 MG/0.67 ML SYRINGE?
KINERET 100 MG/0.67 ML SYRINGE (NDC 66658023428) is labeled by Swedish Orphan Biovitrum AB (publ), and CMS classifies it as a brand product.